Literature DB >> 16755004

Slow acting protein extract from fruit pulp of Momordica charantia with insulin secretagogue and insulinomimetic activities.

Sirintorn Yibchok-anun1, Sirichai Adisakwattana, Cheng Yu Yao, Polkit Sangvanich, Sophon Roengsumran, Walter Haw Hsu.   

Abstract

The protein from Thai bitter gourd (Momordica charantia) fruit pulp was extracted and studied for its hypoglycemic effect. Subcutaneous administration of the protein extract (5, 10 mg/kg) significantly and markedly decreased plasma glucose concentrations in both normal and streptozotocin-induced diabetic rats in a dose-dependent manner. The onset of the protein extract-induced antihyperglycemia/hypoglycemia was observed at 4 and 6 h in diabetic and normal rats, respectively. This protein extract also raised plasma insulin concentrations by 2 fold 4 h following subcutaneous administration. In perfused rat pancreas, the protein extract (10 microg/ml) increased insulin secretion, but not glucagon secretion. The increase in insulin secretion was apparent within 5 min of administration and was persistent during 30 min of administration. Furthermore, the protein extract enhanced glucose uptake into C2C12 myocytes and 3T3-L1 adipocytes. Time course experiments performed in rat adipocytes revealed that M. charantia protein extract significantly increased glucose uptake after 4 and 6 h of incubation. Thus, the M. charantia protein extract, a slow acting chemical, exerted both insulin secretagogue and insulinomimetic activities to lower blood glucose concentrations in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16755004     DOI: 10.1248/bpb.29.1126

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  19 in total

Review 1.  Cardiovascular disease risk reduction in diabetes through conventional and natural approaches.

Authors:  William M Schultz; Elliot N Mahlof; Devinder S Dhindsa; Tina Varghese; Robert E Heinl; Hannah C Cai; Pratik B Sandesara; Danny J Eapen; Laurence S Sperling
Journal:  Cardiovasc Endocrinol       Date:  2017-11-15

Review 2.  Ancient records and modern research on the mechanisms of chinese herbal medicines in the treatment of diabetes mellitus.

Authors:  Hai-Ming Zhang; Feng-Xia Liang; Rui Chen
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-01       Impact factor: 2.629

Review 3.  The use of complementary and alternative medicines (CAMs) in the treatment of diabetes mellitus: is continued use safe and effective?

Authors:  Arjuna B Medagama; Ruwanthi Bandara
Journal:  Nutr J       Date:  2014-10-21       Impact factor: 3.271

4.  Bitter melon juice targets molecular mechanisms underlying gemcitabine resistance in pancreatic cancer cells.

Authors:  Ranganatha R Somasagara; Gagan Deep; Sangeeta Shrotriya; Manisha Patel; Chapla Agarwal; Rajesh Agarwal
Journal:  Int J Oncol       Date:  2015-02-09       Impact factor: 5.650

Review 5.  Beneficial role of bitter melon supplementation in obesity and related complications in metabolic syndrome.

Authors:  Md Ashraful Alam; Riaz Uddin; Nusrat Subhan; Md Mahbubur Rahman; Preeti Jain; Hasan Mahmud Reza
Journal:  J Lipids       Date:  2015-01-12

6.  Cyanidin Stimulates Insulin Secretion and Pancreatic β-Cell Gene Expression through Activation of l-type Voltage-Dependent Ca2+ Channels.

Authors:  Tanyawan Suantawee; Sara T Elazab; Walter H Hsu; Shaomian Yao; Henrique Cheng; Sirichai Adisakwattana
Journal:  Nutrients       Date:  2017-07-28       Impact factor: 5.717

7.  Evaluation of Saptarangyadi Ghanavati in the management of Apathyanimittaja Prameha w.s.r. to type-2 diabetes mellitus.

Authors:  Kanwar Samrat Singh; Harimohan Chandola; Mandip Kaur; B Ravishankar
Journal:  Ayu       Date:  2012-07

8.  Effect of superfine grinding on antidiabetic activity of bitter melon powder.

Authors:  Ying Zhu; Ying Dong; Xiwen Qian; Fengjie Cui; Qin Guo; Xinghua Zhou; Yun Wang; Yi Zhang; Zhiyu Xiong
Journal:  Int J Mol Sci       Date:  2012-11-02       Impact factor: 5.923

9.  Double emulsion-based mayonnaise encapsulated with bitter gourd extract exhibits improvement in vivo anti-diabetic action in STZ induced rats.

Authors:  Urmila Choudhary; Latha Sabikhi; Suman Kapila
Journal:  3 Biotech       Date:  2021-07-04       Impact factor: 2.893

10.  In vitro and in vivo α-amylase and α-glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.).

Authors:  Sundar Poovitha; Madasamy Parani
Journal:  BMC Complement Altern Med       Date:  2016-07-18       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.